Kirby McInerney LLP Reminds Biogen, Inc. (BIIB) Investors
NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S....
Source: globenewswire.com
Biogen Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Biogen Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Biogen Inc Today - Breaking & Trending Today
Bragar Eagel & Squire, P.C. Reminds Investors That Class
NEW YORK, June 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...
Source: globenewswire.com
Biogen Inc.: FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
TOKYO and CAMBRIDGE, Mass., June 09, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts
Source: finanznachrichten.de
Critical Contrast: Biogen (NASDAQ:BIIB) and Poseida Therapeutics (NASDAQ:PSTX)
Biogen (NASDAQ:BIIB – Get Free Report) and Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Profitability This table compares Biogen and Poseida Therapeutics’ net […]
Source: themarketsdaily.com
Protein Therapeutics Market size is set to grow by USD 172.8 billion from 2024-2028, Increased demand for mAbs boost the market, Technavio
/PRNewswire/ -- The global protein therapeutics market size is estimated to grow by USD 172.8 billion from 2024-2028, according to Technavio. The market is...
Source: prnewswire.com